Telomir Pharmaceuticals
Telomir Pharmaceuticals develops a novel treatment that binds critical metals to interrupt enzyme function and returns cellular metals like Iron, copper, and zinc to homeostasis. Telomir 1 is a small molecule being developed as the regulator of telomere length and genomic stability.
Domain
telomirpharma.com
Country
United StatesIndustry
BiotechnologyEmployees
1-10
Last Funding
$5.0M
Founded
2021
Tech Stack (18 technologies)
Frequently Asked Questions
What technologies does Telomir Pharmaceuticals use?+
Telomir Pharmaceuticals uses 18 technologies including Divi, Google Analytics, Google Tag Manager.
What industry is Telomir Pharmaceuticals in?+
Telomir Pharmaceuticals operates in the Biotechnology industry.
Where is Telomir Pharmaceuticals based?+
Telomir Pharmaceuticals is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026